右美托咪定抑制小胶质细胞活化发挥脑保护作用的实验研究

杨桐榉; 王凯; 王震; 陈力勇

doi:10.16016/j.1000-5404.201808004

您当前的位置：

首页 >

文章列表页 >

右美托咪定抑制小胶质细胞活化发挥脑保护作用的实验研究

基础医学 | 更新时间：2026-01-09

- 右美托咪定抑制小胶质细胞活化发挥脑保护作用的实验研究
- Dexmedetomidine protects cerebral ischemia-reperfusion injury by inhibiting microglial activation
- 第三军医大学学报 2018年40卷第23期页码：2197-2203
- 作者机构：
  
  400042 重庆, 陆军军医大学(第三军医大学)第三附属医院(野战外科研究所)麻醉科
- 作者简介：
  
  [ 陈力勇, E-mail: mzkcly@aliyun.com CHEN Liyong, E-mail:mzkcly@aliyun.com
- 基金信息：
- DOI：10.16016/j.1000-5404.201808004
  中图分类号： R743.31;R965;R971.3
- 收稿：2018-08-01，
  
  修回：2018-09-25，
  
  纸质出版：2018-12-15
- 稿件说明：
移动端阅览
杨桐榉, 王凯, 王震, 等. 右美托咪定抑制小胶质细胞活化发挥脑保护作用的实验研究[J]. 第三军医大学学报, 2018,40(23):2197-2203.

Tongju YANG, Kai WANG, Zhen WANG, et al. Dexmedetomidine protects cerebral ischemia-reperfusion injury by inhibiting microglial activation[J]. Journal of Third Military Medical University, 2018, 40(23): 2197-2203.
杨桐榉, 王凯, 王震, 等. 右美托咪定抑制小胶质细胞活化发挥脑保护作用的实验研究[J]. 第三军医大学学报, 2018,40(23):2197-2203. DOI： 10.16016/j.1000-5404.201808004.

Tongju YANG, Kai WANG, Zhen WANG, et al. Dexmedetomidine protects cerebral ischemia-reperfusion injury by inhibiting microglial activation[J]. Journal of Third Military Medical University, 2018, 40(23): 2197-2203. DOI： 10.16016/j.1000-5404.201808004.

摘要

目的

探讨右美托咪定(dexmedetomidine

Dex)对局灶性脑缺血再灌注(ischemia-reperfusion

I/R)损伤的保护作用及其机制。

方法

采用大鼠大脑中动脉栓塞(middle cerebral artery occlusion

MCAO)模型。取60只SD雄性大鼠按随机数字表法分为3组(

=20):Sham组、I/R组和Dex+I/R组。各组评估神经功能情况

检测梗死侧大脑皮层病理改变、半暗带神经细胞凋亡率、小胶质细胞活化率及皮层匀浆TNF-α水平。建立小胶质细胞氧糖剥夺/复氧(oxygen glucose deprivation/reoxygenation

OGD/R)模型。将培养的BV2小胶质细胞分为Control组、OGD/R组和1 μmol/L Dex+OGD/R组、10 μmol/L Dex+OGD/R组。检测细胞上清液TNF-α浓度

及细胞内CD68、NF-κB p65、p-NF-κB p65蛋白表达情况。

结果

与I/R组比较

Dex+I/R组神经功能评分降低(

0.05)

大脑皮层病理损伤减轻

半暗带神经细胞凋亡率降低(

0.05)

小胶质细胞活化率降低(

0.05)

大脑皮层匀浆TNF-α浓度降低(

0.05)。与OGD/R组比较

1 μmol/L Dex+OGD/R组、10 μmol/L Dex+OGD/R组细胞上清液TNF-α浓度降低(

0.05)

10 μmol/L Dex+OGD/R组细胞内CD68、p-NF-κB p65表达减少(

0.05)。

结论

右美托咪定通过抑制小胶质细胞活化减轻脑缺血再灌注损伤发挥脑保护作用

可能与其抑制小胶质细胞NF-κB通路有关。

Abstract

Objective

To investigate the protective effect and underlying mechanism of dexmedetomidine (Dex) on focal cerebral ischemia-reperfusion (I/R) injury.

Methods

Sixty male Sprague-Dawley rats were randomly divided into sham group

I/R group and Dex treatment group

with 20 animals in each group. Rat middle cerebral artery occlusion (MCAO) model was adopted. The neurological function was evaluated

and the pathological changes

apoptotic ratio of nerve cells in penumbra

activation ratio of microglia in penumbra and level of TNF-α in the infarct cerebral cortical homogenate of each group were detected. Mouse microglial BV2 cells were randomly divided into control group

oxygen glucose deprivation/reoxygenation (OGD/R) group

1 μmol/L Dex+OGD/R group

10 μmol/L Dex+OGD/R group. The concentration of TNF-α in the supernatant and the protein levels of CD68

NF-κB p65 and p-NF-κB p65 in the BV2 cells were detected.

Results

Compared with the I/R group

the neurological function score was reduced (

0.05)

pathological damage in the cerebral cortex was attenuated

and the apoptosis ratio of nerve cells (

0.05)

activation ratio of microglia (

0.05) and concentration of TNF-α (

0.05) in the cerebral cortical homogenate were decreased in the Dex+I/R group. Compared with the OGD/R group

Dex treatment decreased the concentration of TNF-α in the supernatant (

0.05)

but only 10 μmol/L Dex decreased the expression of CD68 and p-NF-κB p65 in the BV2 cells (

0.05).

Conclusion

Dex exerts protective effect against cerebral I/R injury by inhibiting microglial activation

which may be related to the inhibition of NF-κB signaling pathway in microglia.

关键词

Keywords

references

MORETTI A, FERRARI F, VILLA R F. Neuroprotection for ischaemic stroke: current status and challenges[J]. Pharmacol Ther, 2015, 146: 23-34. DOI:10.1016/j.pharmthera.2014.09.003.

FEIGIN V L, FOROUZANFAR M H, KRISHNAMURTHI R, et al. Global and regional burden of stroke during 1990-2010: findings from the global burden of disease study 2010[J]. Lancet, 2014, 383(9913): 245-254.

ELTZSCHIG H K, ECKLE T. Ischemia and reperfusion—from mechanism to translation[J]. Nat Med, 2011, 17(11): 1391-1401. DOI:10.1038/nm.2507.

JIN R, YANG G, LI G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells[J]. J Leukoc Biol, 2010, 87(5): 779-789. DOI:10.1189/jlb.1109766.

IADECOLA C, ALEXANDER M. Cerebral ischemia and inflammation[J]. Curr Opin Neurol, 2001, 14(1): 89-94. DOI:10.1016/b978-1-4160-5478-8.10009-0.

WEINSTEIN J R, KOERNER I P, M LLER T. Microglia in ischemic brain injury[J]. Future Neurol, 2010, 5(2): 227-246. DOI:10.2217/fnl.10.1.

ZHU Y M, WANG C C, CHEN L, et al. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats[J]. Brain Res, 2013, 1494: 1-8. DOI:10.1016/j.brainres.2012.11.047.

LEMPI INEN J, FINCKENBERG P, MERVAALA E E, et al. Dexmedetomidine preconditioning ameliorates kidney ischemia- reperfusion injury[J]. Pharmacol Res Perspect, 2014, 2(3):e00045.DOI:10.1002/prp2.45.

RIQUELME J A, WESTERMEIER F, HALL A R, et al.Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism[J]. Pharmacol Res, 2016, 103:318-327.DOI:10.1016/j.phrs.2015.11.004.

BELL M T, AGOSTON V A, FREEMAN K A, et al. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia[J]. J Vasc Surg, 2014, 59(4): 1090-1097. DOI:10.1016/j.jvs.2013.04.050.

LONGA E Z, WEINSTEIN P R, CARLSON S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke, 1989, 20(1): 84-91. DOI:10.1161/01.str.20.1.84.

SCHALLER B, GRAF R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy[J]. J Cereb Blood Flow Metab, 2004, 24(4): 351-371. DOI:10.1097/00004647-200404000-00001.

NAYAK D, ROTH T L, MCGAVERN D B. Microglia development and function[J]. Annu Rev Immunol, 2014, 32: 367-402. DOI:10.1146/annurev-immunol-032713-120240.

CEULEMANS A G, ZGAVC T, KOOIJMAN R, et al. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia[J]. J Neuroinflamm, 2010, 7: 74. DOI:10.1186/1742-2094-7-74.

D'AVILA J C, LAM T I, BINGHAM D, et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor[J]. J Neuroinflamm, 2012, 9: 31. DOI:10.1186/1742-2094-9-31.

陈丽娇, 薛庆生, 于布为.右美托咪定的神经保护作用及其相关机制[J].中国药理学通报, 2015, 31(11):1493-1495. DOI:10.3969/j.issn.1001-1978.2015.11.004.

CHEN L J, XUE Q S, YU B W.Neuroprotection and mechanisms of dexmedetomidine[J]. Chin Pharmacol Bull, 2015, 31(11):1493-1495. DOI:10.3969/j.issn.1001-1978.2015.11.004.

MA Y, WANG J, WANG Y, et al. The biphasic function of microglia in ischemic stroke[J]. Prog Neurobiol, 2017, 157: 247-272. DOI:10.1016/j.pneurobio.2016.01.005.

BOK S, WANG T, LEE C J, et al. In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy[J ] . Biomed Opt Express, 2015, 6(9): 3303-3312. DOI:10.1364/BOE.6.003303.

TAKEUCHI H, JIN S, WANG J, ZHANG G, et al.Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner[J ] . J Biol Chem, 2006, 28;281(30):21362-21368. DOI:10.1074/jbc.M600504200.

GREGERSEN R, LAMBERTSEN K, FINSEN B. Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice[J]. J Cereb Blood Flow Metab, 2000, 20(1): 53-65. DOI:10.1097/00004647-200001000-00009.

AONO H, CHOUDHURY M E, HIGAKI H, et al. Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus[J]. Glia, 2017, 65(11): 1833-1847. DOI:10.1002/glia.23199.

STAROSSOM S C, MASCANFRONI I D, IMITOLA J, et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration[J]. Immunity, 2012, 37(2): 249-263. DOI:10.1016/j.immuni.2012.05.023.

FRAKES A, FERRAIUOLO L, HAIDET-PHILLIPS A, et al. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis[J ] . Neuron, 2014, 81(5): 1009-1023. DOI:10.1016/j.neuron.2014.01.013.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

右美托咪定通过抑制mTOR/NF-κB信号通路减轻七氟烷诱导的新生大鼠认知功能障碍

甲基莲心碱通过抑制ROS/NLRP3/Caspase-1通路减少小胶质细胞焦亡并改善帕金森病神经炎症

SOCS3通过抑制NF-κB信号通路介导的小胶质细胞炎症反应改善帕金森病神经损伤

右美托咪定预处理周细胞增强细胞治疗对脓毒症小鼠急性肺损伤的保护作用

不同浓度右美托咪定对大鼠心脏死亡后供体肾脏的影响